Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

LMA Protector vs I-Gel in Low-Flow Anesthesia for Laparoscopic Cholecystectomy

NCT: NCT07707440 · COMPLETED

NCT IDNCT07707440
StatusCOMPLETED
Start Date2020-07-01
Completion2020-10-31
SponsorFatih Sultan Mehmet Training and Research Hospital (OTHER)
First posted
Last updated

Brief Summary

This prospective randomized study aims to compare two second-generation supraglottic airway devices (SGAs), the I-Gel and the laryngeal mask airway (LMA) Protector, in patients undergoing laparoscopic cholecystectomy under low-flow desflurane anesthesia. The study evaluates the devices in terms of respiratory mechanics (dynamic compliance, peak inspiratory pressure, plateau pressure, and airway resistance), non-invasive perfusion parameters (oxygen reserve index, perfusion index, and pleth variability index), hemodynamic stability, ease of insertion, oropharyngeal leak pressure, and postoperative complication rates.

Frequently Asked Questions

What is LMA Protector vs I-Gel in Low-Flow Anesthesia for Laparoscopic Cholecystectomy?

LMA Protector vs I-Gel in Low-Flow Anesthesia for Laparoscopic Cholecystectomy is a clinical trial registered under NCT07707440. Current status: COMPLETED.

What is the status of NCT07707440?

The current status of NCT07707440 (LMA Protector vs I-Gel in Low-Flow Anesthesia for Laparoscopic Cholecystectomy) is: COMPLETED.

When did LMA Protector vs I-Gel in Low-Flow Anesthesia for Laparoscopic Cholecystectomy start?

LMA Protector vs I-Gel in Low-Flow Anesthesia for Laparoscopic Cholecystectomy started on 2020-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.